ScholarLens Back to search
1996•Unpublished venueRequires access

Effects of somatostatin in treating acute pancreatitis

Shi Du

Open publisher page 0 citations

Abstract

AIM:To observe the effects of somatostatin in treating acute pancreatitis.METHODS:The somatostatin group including 8 patients with acute edematic pancreatitis(AEP) and 12 patients with acute severe pacreatitis (ASP) received a 3-7day infusion of somatostatin(250μg/h).The control group including 8 patients with AEP and 12 patients with ASP was treated without somatostatin. The severities were similar between the two groups according to APACHE Ⅱ scores. RESULTS:The treating outcomes of the two groups were compard.The duration of the return of serum amylase levels to normal and hospital stay of somatostatin group with ASP were less than those of the control group with ASP significantly (P0.05).But there was no significant difference between the two groups with AEP(P0.05).CONCLUSION:Somatostatin exerted its beneficial effects in treating ASP.

About this research paper

What this paper is about

AIM:To observe the effects of somatostatin in treating acute pancreatitis.METHODS:The somatostatin group including 8 patients with acute edematic pancreatitis(AEP) and 12 patients with acute severe pacreatitis (ASP) received a 3-7day infusion of somatostatin(250μg/h).The control group including 8 patients with AEP and 12 patients with ASP was treated without somatostatin. The severities were similar between the two groups according to APACHE Ⅱ scores. RESULTS:The treating outcomes of the two groups were compard.The duration of the return of serum amylase levels to normal and hospital stay of somatostatin group with ASP were less than those of the control group with ASP significantly (P0.05).But there was no significant difference between the two groups with AEP(P0.05).CONCLUSION:Somatostatin exerted its beneficial effects in treating ASP.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To observe the effects of somatostatin in treating acute pancreatitis.METHODS:The somatostatin group including 8 patients with acute edematic pancreatitis(AEP) and 12 patients with acute severe pacreatitis (ASP) received a 3-7day infusion of somatostatin(250μg/h).The control group including 8 patients with AEP and 12 patients with ASP was treated without somatostatin. The severities were similar between the two groups according to APACHE Ⅱ scores. RESULTS:The treating outcomes of the two groups were compard.The duration of the return of serum amylase levels to normal and hospital stay of somatostatin group with ASP were less than those of the control group with ASP significantly (P0.05).But there was no significant difference between the two groups with AEP(P0.05).CONCLUSION:Somatostatin exerted its beneficial effects in treating ASP.

Key concepts: Somatostatin, Medicine, Acute pancreatitis, Pancreatitis, Internal medicine, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effects of somatostatin in treating acute pancreatitis — Research Paper | ScholarLens